Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Personnel

Waratek Names Douglas Ennis Chief Executive Officer


Waratek, an award-winning pioneer in the next generation of application security solutions, today announced that it has appointed Douglas Ennis to Chief Executive Officer. To meet growing demand for its solutions and better serve its global customer base, the firm has also launched a new US head office in Chicago's Fulton Market District and moved into a new, expanded worldwide headquarters in South Docklands, Dublin, Ireland.

With over 20 years' experience ranging from application development, internal IT, consulting and sales, Doug has a proven track record and deep understanding of the cybersecurity and networking landscapes. Prior to joining Waratek as Chief Revenue Officer in May of 2021, Doug has held sales leadership roles in companies focused on data privacy, network security, application performance management and mobile device management. In his elevated role, Doug will focus on driving deeper penetration of Waratek's award-winning technology into the expanding cybersecurity verticals and sectors.

"Between Doug's background in the security industry and his track record for achieving strong business growth and development, he's the right person to take Waratek to the next level," said Chris Rouland, Board Director at Waratek. "With application security threats intensifying across many industries, Waratek is positioned for rapid growth over the next few years and Doug's stewardship will play an important role in making that happen."

Ennis adds, "Waratek has built a culture of relentless innovation and agility that allows us to help customers meet today's evolving threat landscape. Today, I am thrilled to lead Waratek into its next phase, as we expand our patented Autonomous Rule Management Runtime platform (ARMR) to provide API security, and move towards becoming the first fully programmable Application Security Platform to defend both your applications and APIs."

"Everything we do at Waratek is built around our culture and Doug's infectious energy has inspired the team from day one," said John Matthew Holt, Founder of Waratek. "His grasp of the underlying capabilities of our patented security innovations within the ARMR Platform and the possibilities of future challenges we can solve for, makes me very excited to see where Doug leads us in the years ahead."

To learn more about how Waratek delivers runtime security and real-time protection, visit https://www.waratek.com/.

About Waratek:
Leading global companies use Waratek's ARMR Security Platform to patch, secure and upgrade their mission critical applications. A pioneer in the next generation of application security solutions, Waratek makes it easy for security teams to instantly detect and remediate known vulnerabilities with no downtime, protect their applications from known and Zero Day attacks, and virtually upgrade out-of-support Java applications ? all without time consuming and expensive source code changes or unacceptable performance overhead.


These press releases may also interest you

18 mai 2024
Celltrion partners with TV star Mollie Pearce to launch the second installation of the Where's Crohn's & Colitis (CC)? campaign for this year's World IBD Day (19 May 2024). The campaign focuses on access to IBD care and treatment as the burden of...

18 mai 2024
The global industrial automation market in life sciences industry  size is estimated to grow by USD 5.06 bn from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  11.4%  during the forecast period. ...

18 mai 2024
"Maximizing customer retention and expansion is more important than ever for B2B SaaS companies," said Steven Forth, CEO of Ibbaka. "Our...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...

18 mai 2024
After tens of thousands of NYC children were turned away from "Summer Rising," New York City's popular, free summer enrichment program, Brains & Motion launched a campaign offering camps at NYU for a small fraction of the up-to-$1400 per week price...



News published on and distributed by: